Holocene Advisors, LP Charles River Laboratories International, Inc. Transaction History

Holocene Advisors, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$203.52 - $273.43 $6.53 Million - $8.77 Million	32,078 New	32,078 $8.69 Million
Q1 2023 May 15, 2023	SELL	$191.89 - $259.92 $947,552 - $1.28 Million	-4,938 Reduced 72.96%	1,830 $369,000
Q4 2022 Feb 14, 2023	SELL	$197.11 - $250.07 $28.5 Million - $36.1 Million	-144,377 Reduced 95.52%	6,768 $1.47 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $27.6 Million - $37.9 Million	151,145 New	151,145 $29.7 Million

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.